A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema

Clinical trial NCT01320566 · TERMINATED

Trial details

NCT number: NCT01320566
Sponsor: Aeris Therapeutics
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Pulmonary Emphysema Chronic Obstructive Pulmonary Disease(COPD)Lung Diseases

Start date: 2011-03-01
Primary completion: 2012-01-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.